These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9364984)
21. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770 [TBL] [Abstract][Full Text] [Related]
22. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
23. Discovery of a novel, potent, and specific family of factor Xa inhibitors via combinatorial chemistry. Ostrem JA; al-Obeidi F; Safar P; Safarova A; Stringer SK; Patek M; Cross MT; Spoonamore J; LoCascio JC; Kasireddy P; Thorpe DS; Sepetov N; Lebl M; Wildgoose P; Strop P Biochemistry; 1998 Jan; 37(4):1053-9. PubMed ID: 9454596 [TBL] [Abstract][Full Text] [Related]
24. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis. Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049 [TBL] [Abstract][Full Text] [Related]
25. Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray. Gosalia DN; Denney WS; Salisbury CM; Ellman JA; Diamond SL Biotechnol Bioeng; 2006 Aug; 94(6):1099-110. PubMed ID: 16575920 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Backes BJ; Harris JL; Leonetti F; Craik CS; Ellman JA Nat Biotechnol; 2000 Feb; 18(2):187-93. PubMed ID: 10657126 [TBL] [Abstract][Full Text] [Related]
27. Fluorogenic peptide-based substrates for monitoring thrombin activity. van Berkel SS; van der Lee B; van Delft FL; Wagenvoord R; Hemker HC; Rutjes FP ChemMedChem; 2012 Apr; 7(4):606-17. PubMed ID: 22294421 [TBL] [Abstract][Full Text] [Related]
28. BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for Arg over Lys in P1: Role of N-glycosylation in thermostability and active site accessibility. Silva-Junior FP; Guedes HL; Garvey LC; Aguiar AS; Bourguignon SC; Di Cera E; Giovanni-De-Simone S Toxicon; 2007 Jul; 50(1):18-31. PubMed ID: 17433397 [TBL] [Abstract][Full Text] [Related]
29. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. Gouvea IE; Izidoro MA; Judice WA; Cezari MH; Caliendo G; Santagada V; dos Santos CN; Queiroz MH; Juliano MA; Young PR; Fairlie DP; Juliano L Arch Biochem Biophys; 2007 Jan; 457(2):187-96. PubMed ID: 17184724 [TBL] [Abstract][Full Text] [Related]
30. Sensitivity and specificity of plasma serine protease chromogenic substrates. Bang NU; Mattler LE Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051 [TBL] [Abstract][Full Text] [Related]
31. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro. Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599 [TBL] [Abstract][Full Text] [Related]
33. Engineering of a macromolecular scaffold to develop specific protease inhibitors. Stoop AA; Craik CS Nat Biotechnol; 2003 Sep; 21(9):1063-8. PubMed ID: 12923547 [TBL] [Abstract][Full Text] [Related]
34. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379 [TBL] [Abstract][Full Text] [Related]
35. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Harris JL; Backes BJ; Leonetti F; Mahrus S; Ellman JA; Craik CS Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7754-9. PubMed ID: 10869434 [TBL] [Abstract][Full Text] [Related]
36. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis. Bhongade BA; Gouripur VV; Gadad AK Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388 [TBL] [Abstract][Full Text] [Related]
37. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems. Chmielewska J; Latallo ZS Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591 [TBL] [Abstract][Full Text] [Related]
38. Proteolytic modulation of thrombopoietin activity: comparison of thrombin, plasmin, and urokinase. Reiner AP; Aramaki KM Thromb Haemost; 2000 Jun; 83(6):909-14. PubMed ID: 10896248 [TBL] [Abstract][Full Text] [Related]
39. [ANSA analysis. I. Mixtures of substrates in analyzing proteases: features of the kinetics of hydrolysis during competition]. Nedospasov AA; Lifanov AP; Rodina EV Biokhimiia; 1994 Oct; 59(10):1511-20. PubMed ID: 7819393 [TBL] [Abstract][Full Text] [Related]
40. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase. Yomtova VM; Stambolieva NA; Blagoev BM Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]